PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
RXST vs. ALPN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

RXST vs. ALPN

Last updated Apr 27, 2025

Compare and contrast key facts about RxSight, Inc. (RXST) and Alpine Immune Sciences, Inc. (ALPN).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RXST or ALPN.

Correlation

The correlation between RXST and ALPN is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

-0.50.00.51.0
Correlation: 0.3

Performance

RXST vs. ALPN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RxSight, Inc. (RXST) and Alpine Immune Sciences, Inc. (ALPN). The values are adjusted to include any dividend payments, if applicable.
0.00%100.00%200.00%300.00%400.00%500.00%600.00%NovemberDecember2025FebruaryMarchApril
-6.56%
634.95%
RXST
ALPN

Key characteristics

Fundamentals

Market Cap

RXST:

$607.27M

ALPN:

$4.46B

EPS

RXST:

-$0.71

ALPN:

-$0.64

PS Ratio

RXST:

4.34

ALPN:

71.68

PB Ratio

RXST:

2.13

ALPN:

12.87

Returns By Period

RXST

YTD

-56.52%

1M

-43.94%

6M

-70.33%

1Y

-71.67%

5Y*

N/A

10Y*

N/A

ALPN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

RXST vs. ALPN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
RXST
The Risk-Adjusted Performance Rank of RXST is 22
Overall Rank
The Sharpe Ratio Rank of RXST is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of RXST is 22
Sortino Ratio Rank
The Omega Ratio Rank of RXST is 22
Omega Ratio Rank
The Calmar Ratio Rank of RXST is 22
Calmar Ratio Rank
The Martin Ratio Rank of RXST is 22
Martin Ratio Rank
ALPN
The Risk-Adjusted Performance Rank of ALPN is 5353
Overall Rank
The Sharpe Ratio Rank of ALPN is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of ALPN is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ALPN is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ALPN is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ALPN is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RXST vs. ALPN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Alpine Immune Sciences, Inc. (ALPN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The chart of Sharpe ratio for RXST, currently valued at -1.17, compared to the broader market-2.00-1.000.001.002.003.00
RXST: -1.17
ALPN: 1.56
The chart of Sortino ratio for RXST, currently valued at -2.03, compared to the broader market-6.00-4.00-2.000.002.004.00
RXST: -2.03
ALPN: 3.34
The chart of Omega ratio for RXST, currently valued at 0.69, compared to the broader market0.501.001.502.00
RXST: 0.69
ALPN: 3.33
The chart of Calmar ratio for RXST, currently valued at -0.93, compared to the broader market0.001.002.003.004.005.00
RXST: -0.93
ALPN: 3.83
The chart of Martin ratio for RXST, currently valued at -1.90, compared to the broader market-5.000.005.0010.0015.0020.00
RXST: -1.90
ALPN: 27.42

Rolling 12-month Sharpe Ratio-2.000.002.004.006.008.00NovemberDecember2025FebruaryMarchApril
-1.17
1.56
RXST
ALPN

Dividends

RXST vs. ALPN - Dividend Comparison

Neither RXST nor ALPN has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

RXST vs. ALPN - Drawdown Comparison

-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-76.75%
-0.00%
RXST
ALPN

Volatility

RXST vs. ALPN - Volatility Comparison

RxSight, Inc. (RXST) has a higher volatility of 51.25% compared to Alpine Immune Sciences, Inc. (ALPN) at 0.00%. This indicates that RXST's price experiences larger fluctuations and is considered to be riskier than ALPN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
51.25%
0
RXST
ALPN

Financials

RXST vs. ALPN - Financials Comparison

This section allows you to compare key financial metrics between RxSight, Inc. and Alpine Immune Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Values in USD except per share items